Displaying items by tag: department of health behavior

The UAB School of Public Health’s new Magic City LGBTQ Health Studies Endowed Professorship aims to champion research and education and address health disparities among the LGBTQ community in Alabama and the Deep South. 

UAB researchers will study psilocybin, a psychedelic compound, on its effects on smoking cessation.     
A graduate of UAB was awarded for her outstanding presentation at the Association for the Advancement of Automotive Medicine in Madrid, Spain.
According to the study, novel psychedelic use is rare, and the majority of people who reported using novel psychedelics were white men who were of college age or had recently graduated from college.
Greg Pavela, Ph.D., will lead the UAB team to study why some people are more susceptible to the health consequences of obesity than others.
Pavela will serve as the chair-elect and then chair of the Ethics Section for the American Public Health Association.
The study’s findings show the benefits of the ketogenic diet in cancer patients, and the authors hope to expand their research to see if it will also impact cancer treatment.
A UAB study suggests that psychedelic drugs have a positive effect on antisocial, criminal behavior, warranting investigation of psychedelics as a crime reduction therapy.

UAB clinical psychologist Josh Klapow, Ph.D., discusses the importance of evaluating activities and setting ground rules to keep from getting overbooked.

Mild to moderate muscle and nerve strain provokes symptom flares in individuals with chronic fatigue syndrome.
Experts take an in-depth look into a favorite college pastime by understanding the dangers and risks of alcohol.
Foods high in fats have long been put into the “unhealthy” category by nutrition experts, but UAB researchers believe this may have been all wrong, all along.
A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
Classic psychedelic drugs include LSD, psilocybin and mescaline. This new School of Public Health research is published in the Journal of Psychopharmacology.
Page 1 of 2